Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 9, 2010, Pages 1042-1050

  Vannella, L ^a   Lahner, E ^a   Osborn, J ^b   Bordi, C ^c   Miglione, M ^a   Delle Fave, G ^a   Annibale, B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM DETECTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROSCOPY; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; STOMACH TUMOR; ADENOCARCINOMA; ADOLESCENT; EPIDEMIOLOGY; MIDDLE AGED; PATHOLOGY; PRECANCER; STOMACH MUCOSA; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 77950555369     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04268.x     Document Type: Article

References (32)

1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base n.5 version 2.0, IARC Press
2. Hundahl SA, Menck HR, Mansour EG, et al. The National Cancer Data Base report on gastric carcinoma. Cancer 1997 80 : 2333 2341. (Pubitemid 28007405)
3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992 52 : 6735 6740. (Pubitemid 23006271)
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345 : 784 789.
5. Meining A, Morgner A, Miehlke S, et al. Atrophy-metaplasia-dysplasia- carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001 15 : 983 998. (Pubitemid 34110604)
6. Miehlke S, Hackelsberger A, Meining A, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998 78 : 263 266. (Pubitemid 28302267)
7. Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996 38 : 171 176.
8. Annibale B, Capurso G, Lahner E, et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 2003 52 : 496 501. (Pubitemid 36363399)
9. Haber MM. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol Clin North Am 2002 31 : 395 419.
10. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002 50 : 378 381. (Pubitemid 34161055)
11. Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther 2005 22 : 471 481. (Pubitemid 41248115)
12. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol 2004 57 : 177 182. (Pubitemid 38177758)
13. Hirota WK, Zuckerman MJ, Adler DG, et al. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006 63 : 570 580.
14. de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007 12 : 1 15. (Pubitemid 46105914)
15. Annibale B, Marignani M, Azzoni C, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997 2 : 57 64. (Pubitemid 127686148)
16. Lahner E, Bordi C, Di Giulio E, et al. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther 2002 16 : 507 514. (Pubitemid 34214530)
17. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20 : 1161 1181.
18. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000 24 : 167 176. (Pubitemid 30078704)
19. Stanley RH, Lauri AA, et al. Pathology and Genetics of Tumours of Digestive System.
20. Marignani M, Delle Fave G, Mecarocci S, et al. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am J Gastroenterol 1999 94 : 766 772. (Pubitemid 29124879)
21. Annibale B, Lahner E, Bordi C, et al. Role of Helicobacter pylori infection in pernicious anaemia. Dig Liver Dis 2000 32 : 756 762. (Pubitemid 32098072)
22. Lahner E, Caruana P, D'Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc 2001 53 : 443 448. (Pubitemid 33586752)
23. Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on gastric epithelial dysplasia. Gastroenterology 1994 107 : 1288 1296.
24. Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005 36 : 228 233. (Pubitemid 40404005)
25. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004 53 : 1244 1249.
26. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008 134 : 945 952. (Pubitemid 351451990)
27. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000 95 : 1431 1438. (Pubitemid 30396299)
28. Kokkola A, Sjöblom SM, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998 33 : 88 92. (Pubitemid 28114075)
29. Strickland RG, Mackay IR. A reappraisal of the nature and significante of chronic atrrophic gastritis. Am J Dig Dis 1973 18 : 426 440.
30. WHO. Global InfoBase: The Impact of Cancer in Your Country. Available at: http://apps.who.int/infobase/report.aspx?rid=153&iso=ITA. Accessed July 2009.
31. Lahner E, Vaira D, Figura N, et al. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2004 9 : 436 442. (Pubitemid 39273948)
32. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004 291 : 187 194.